Transcutaneous Electrical Acustimulation in Automatic Synchronization With Breathing for Treating Functional Dyspepsia: A Phase I Feasibility Trial
The AutoSTEA device, developed by MetroHealth Medical Center, aims to address functional dyspepsia, a condition affecting a significant portion of the adult population. The feasibility trial will assess both the efficacy and safety of the device, which could position it as a novel non-pharmacological treatment option in a market currently dominated by pharmacotherapy. Given the increasing prevalence of functional gastrointestinal disorders and the growing demand for at-home treatment solutions, successful outcomes could lead to a competitive advantage in the gastrointestinal device market. However, the trial's limited enrollment of 20 participants may pose challenges in establishing robust market claims. The focus on usability and safety is critical for patient acceptance and adherence, which are essential for commercial success.
Indication: Functional Dyspepsia
Modality: medical device
Target: Transcutaneous electrical acustimulation synchronized with breathing mechanisms for symptom relief in functional dyspepsia.
Sponsor: MetroHealth Medical Center
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 21, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Transcutaneous electrical acustimulation synchronized with breathing mechanisms for symptom relief in functional dyspepsia.
View original source fields
Condition raw: Functional Dyspepsia
Condition normalized: Functional Dyspepsia
Modality raw: medical device
Modality normalized: medical device
Target raw: Transcutaneous electrical acustimulation synchronized with breathing mechanisms for symptom relief in functional dyspepsia.
Target normalized: Transcutaneous electrical acustimulation synchronized with breathing mechanisms for symptom relief in functional dyspepsia.